See also this year's filing and all EDGAR filings for this company.
PDF Report 0001662524_2019_AKCEA_THERAPEUTICS_INC.pdf
Logs
error | IME and Company effects mismatched for Selling, General and Administrative Expense. IME Effects: 28.7, Company Effect: 28.6 | subcommand.report | {} |
warning | Missing logo | subcommand.report | {} |
info | original effects; company_effects: -28.65, ime_effects: -28.7 | subcommand.report | {} |
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.03141653024973007, 'aggregate_val': 296130000, 'exp_sum': 287110000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 153610000, 'ResearchAndDevelopmentExpense': 130340000, 'remainder_Expenses': 3160000}} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001662524')"} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001662524, AKCEA THERAPEUTICS INC.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 267,235,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 88,914,000 |
2 | PropertyPlantAndEquipmentNet | 5,696,000 |
3 | remainder_Assets | 3,416,000 |
4 | LiabilitiesCurrent | 80,661,000 |
5 | LiabilitiesNoncurrent | 3,434,000 |
6 | remainder_Liabilities | 4,442,000 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 153,610,000 |
9 | ResearchAndDevelopmentExpense | 130,340,000 |
10 | remainder_Expenses | 12,180,000 |
11 | remainder_Revenues | 64,867,000 |
12 | remainder_NetIncome | 5,442,000 |
13 | remainder_ComprehensiveNetIncome | 127,000 |
yvar | yval | |
---|---|---|
0 | Assets | 365,261,000 |
1 | Liabilities | 88,537,000 |
2 | Expenses | 296,130,000 |
3 | Revenues | 64,867,000 |
4 | StockholdersEquity | 276,724,000 |
5 | NetIncome | -225,821,000 |
6 | ComprehensiveNetIncome | -225,757,500 |
7 | BaseVar | 410,182,000 |
8 | EconomicCapitalRatio | 1.10 |